Table 1 Main patient characteristics
ID | Age | BMI | Histologic Subtype | Platinum Free Interval | Stage | Prior Treatment Lines | Months of disease before treatment | CT Response | PET Response |
|---|---|---|---|---|---|---|---|---|---|
01 | 56 | 24 | Endometroid | Resistant | III | 3 | 31 | Partial Response | Partial Response |
02 | 72 | 19 | Serous | Partially sensitive | IV | 3 | 25 | Progression Disease | Progression Disease |
03 | 59 | 25 | Endometroid | Resistant | IV | 3 | 23 | Partial Response | Complete Response |
04 | 54 | 23 | Serous | Resistant | IV | 4 | 17 | - | Complete Response |
05 | 54 | 21 | Serous | Partially sensitive | IV | 5 | 36 | Partial Response | Partial Response |
06 | 53 | 26 | Serous | Resistant | IV | 5 | 53 | Complete Response | Complete Response |
07 | 48 | 17 | Serous | Resistant | III | 3 | 26 | Partial Response | Partial Response |
08 | 56 | 24 | Serous | Resistant | III | 3 | 9 | Complete Response | Complete Response |
09 | 70 | 32 | Serous | Resistant | IV | 5 | 60 | Complete Response | - |
10 | 61 | 28 | Serous | Partially sensitive | III | 5 | 68 | Partial Response | Progression Disease |
11 | 66 | 26 | Serous | Resistant | III | 3 | 28 | Partial Response | Complete Response |
12 | 70 | 20 | Serous | Partially sensitive | III | 3 | 37 | Complete Response | Complete Response |
13 | 70 | 20 | Serous | Resistant | III | 3 | 13 | Stable Disease | Stable Disease |
14 | 49 | 20 | Serous | Partially sensitive | IV | 3 | 27 | Partial Response | Partial Response |
15 | 62 | 22 | Serous | Resistant | IV | 4 | 8 | - | - |